Lipocalin 2 receptors: facts, fictions, and myths

The human 25-kDa Lipocalin 2 (LCN2) was first identified and purified as a protein that in part is associated with gelatinase from neutrophils. This protein shows a high degree of sequence similarity with the deduced sequences of rat α2-microglobulin-related protein and the mouse protein 24p3. Based...

Full description

Bibliographic Details
Main Authors: Sarah K. Schröder, Natalie Gasterich, Sabine Weiskirchen, Ralf Weiskirchen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1229885/full
_version_ 1797744753540857856
author Sarah K. Schröder
Natalie Gasterich
Sabine Weiskirchen
Ralf Weiskirchen
author_facet Sarah K. Schröder
Natalie Gasterich
Sabine Weiskirchen
Ralf Weiskirchen
author_sort Sarah K. Schröder
collection DOAJ
description The human 25-kDa Lipocalin 2 (LCN2) was first identified and purified as a protein that in part is associated with gelatinase from neutrophils. This protein shows a high degree of sequence similarity with the deduced sequences of rat α2-microglobulin-related protein and the mouse protein 24p3. Based on its typical lipocalin fold, which consists of an eight-stranded, anti-parallel, symmetrical β-barrel fold structure it was initially thought that LCN2 is a circulating protein functioning as a transporter of small lipophilic molecules. However, studies in Lcn2 null mice have shown that LCN2 has bacteriostatic properties and plays a key role in innate immunity by sequestering bacterial iron siderophores. Numerous reports have further shown that LCN2 is involved in the control of cell differentiation, energy expenditure, cell death, chemotaxis, cell migration, and many other biological processes. In addition, important roles for LCN2 in health and disease have been identified in Lcn2 null mice and multiple molecular pathways required for regulation of Lcn2 expression have been identified. Nevertheless, although six putative receptors for LCN2 have been proposed, there is a fundamental lack in understanding of how these cell-surface receptors transmit and amplify LCN2 to the cell. In the present review we summarize the current knowledge on LCN2 receptors and discuss inconsistencies, misinterpretations and false assumptions in the understanding of these potential LCN2 receptors.
first_indexed 2024-03-12T15:13:49Z
format Article
id doaj.art-2ca33f67f94444529fb2d3066fa0ad68
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T15:13:49Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-2ca33f67f94444529fb2d3066fa0ad682023-08-11T17:09:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-08-011410.3389/fimmu.2023.12298851229885Lipocalin 2 receptors: facts, fictions, and mythsSarah K. Schröder0Natalie Gasterich1Sabine Weiskirchen2Ralf Weiskirchen3Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, GermanyInstitute of Neuroanatomy, RWTH University Hospital Aachen, Aachen, GermanyInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, GermanyInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, GermanyThe human 25-kDa Lipocalin 2 (LCN2) was first identified and purified as a protein that in part is associated with gelatinase from neutrophils. This protein shows a high degree of sequence similarity with the deduced sequences of rat α2-microglobulin-related protein and the mouse protein 24p3. Based on its typical lipocalin fold, which consists of an eight-stranded, anti-parallel, symmetrical β-barrel fold structure it was initially thought that LCN2 is a circulating protein functioning as a transporter of small lipophilic molecules. However, studies in Lcn2 null mice have shown that LCN2 has bacteriostatic properties and plays a key role in innate immunity by sequestering bacterial iron siderophores. Numerous reports have further shown that LCN2 is involved in the control of cell differentiation, energy expenditure, cell death, chemotaxis, cell migration, and many other biological processes. In addition, important roles for LCN2 in health and disease have been identified in Lcn2 null mice and multiple molecular pathways required for regulation of Lcn2 expression have been identified. Nevertheless, although six putative receptors for LCN2 have been proposed, there is a fundamental lack in understanding of how these cell-surface receptors transmit and amplify LCN2 to the cell. In the present review we summarize the current knowledge on LCN2 receptors and discuss inconsistencies, misinterpretations and false assumptions in the understanding of these potential LCN2 receptors.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1229885/fullNGALRSLC22A17MegalinLRP2MC4Rinflammation
spellingShingle Sarah K. Schröder
Natalie Gasterich
Sabine Weiskirchen
Ralf Weiskirchen
Lipocalin 2 receptors: facts, fictions, and myths
Frontiers in Immunology
NGALR
SLC22A17
Megalin
LRP2
MC4R
inflammation
title Lipocalin 2 receptors: facts, fictions, and myths
title_full Lipocalin 2 receptors: facts, fictions, and myths
title_fullStr Lipocalin 2 receptors: facts, fictions, and myths
title_full_unstemmed Lipocalin 2 receptors: facts, fictions, and myths
title_short Lipocalin 2 receptors: facts, fictions, and myths
title_sort lipocalin 2 receptors facts fictions and myths
topic NGALR
SLC22A17
Megalin
LRP2
MC4R
inflammation
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1229885/full
work_keys_str_mv AT sarahkschroder lipocalin2receptorsfactsfictionsandmyths
AT nataliegasterich lipocalin2receptorsfactsfictionsandmyths
AT sabineweiskirchen lipocalin2receptorsfactsfictionsandmyths
AT ralfweiskirchen lipocalin2receptorsfactsfictionsandmyths